Advertisement
Australia markets close in 4 hours 2 minutes
  • ALL ORDS

    8,034.30
    +31.50 (+0.39%)
     
  • ASX 200

    7,791.40
    +31.80 (+0.41%)
     
  • AUD/USD

    0.6629
    -0.0023 (-0.34%)
     
  • OIL

    82.11
    +0.37 (+0.45%)
     
  • GOLD

    2,331.20
    -5.40 (-0.23%)
     
  • Bitcoin AUD

    93,534.27
    +1,725.66 (+1.88%)
     
  • CMC Crypto 200

    1,289.35
    +23.21 (+1.83%)
     
  • AUD/EUR

    0.6198
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0931
    +0.0004 (+0.04%)
     
  • NZX 50

    11,717.43
    -117.59 (-0.99%)
     
  • NASDAQ

    19,789.03
    +37.98 (+0.19%)
     
  • FTSE

    8,179.68
    -45.65 (-0.55%)
     
  • Dow Jones

    39,164.06
    +36.26 (+0.09%)
     
  • DAX

    18,210.55
    +55.31 (+0.30%)
     
  • Hang Seng

    17,758.44
    +41.97 (+0.24%)
     
  • NIKKEI 225

    39,731.50
    +389.96 (+0.99%)
     

Johnson & Johnson (NYSE:JNJ) is largely controlled by institutional shareholders who own 71% of the company

Key Insights

  • Given the large stake in the stock by institutions, Johnson & Johnson's stock price might be vulnerable to their trading decisions

  • 42% of the business is held by the top 25 shareholders

  • Insiders have been selling lately

Every investor in Johnson & Johnson (NYSE:JNJ) should be aware of the most powerful shareholder groups. With 71% stake, institutions possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

Since institutional have access to huge amounts of capital, their market moves tend to receive a lot of scrutiny by retail or individual investors. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait.

ADVERTISEMENT

Let's delve deeper into each type of owner of Johnson & Johnson, beginning with the chart below.

See our latest analysis for Johnson & Johnson

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Johnson & Johnson?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

We can see that Johnson & Johnson does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Johnson & Johnson's historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
earnings-and-revenue-growth

Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. We note that hedge funds don't have a meaningful investment in Johnson & Johnson. The Vanguard Group, Inc. is currently the company's largest shareholder with 9.5% of shares outstanding. BlackRock, Inc. is the second largest shareholder owning 7.9% of common stock, and State Street Global Advisors, Inc. holds about 5.5% of the company stock.

On studying our ownership data, we found that 25 of the top shareholders collectively own less than 50% of the share register, implying that no single individual has a majority interest.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

Insider Ownership Of Johnson & Johnson

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our data suggests that insiders own under 1% of Johnson & Johnson in their own names. Being so large, we would not expect insiders to own a large proportion of the stock. Collectively, they own US$265m of stock. It is good to see board members owning shares, but it might be worth checking if those insiders have been buying.

General Public Ownership

The general public, who are usually individual investors, hold a 28% stake in Johnson & Johnson. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks for example - Johnson & Johnson has 2 warning signs we think you should be aware of.

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.